-+ 0.00%
-+ 0.00%
-+ 0.00%

Outlook Therapeutics names Kevin Lundquist CFO

PUBT·10/06/2026 13:20:19
Listen to the news
Outlook Therapeutics names Kevin Lundquist CFO
  • Outlook Therapeutics appointed Kevin Lundquist as chief financial officer as it shifts to a commercial-stage launch of LYTENAVA.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Outlook Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610060920PRIMZONEFULLFEED9839969) on October 06, 2026, and is solely responsible for the information contained therein.